Latvia - Cardiovascular System Medicine Use
Since 2014, Latvia Cardiovascular System Medicine Use grew 2.3% year on year. In 2019, the country was number 26 among other countries in Cardiovascular System Medicine Use with 313.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Israel, which was ranked number 25 at 316.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea with 217.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 726.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +0.4% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +3.9% per year, while Slovakia witnessed the worst performance at -4.5% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 313.30 |
2018 | 298.60 |
2017 | 297.80 |
2016 | 283.70 |
2015 | 282.50 |
How does Latvia rank in Cardiovascular System Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Hungary
|
727 | 2019 | +0.4 % | +0.2 % | View data | |
2 |
#2
Germany
|
713 | 2019 | +2.2 % | +0.8 % | View data | |
25 |
#25
Israel
|
317 | 2019 | -0.4 % | -1.1 % | View data | |
26 |
#26
Latvia
|
313 | 2019 | +4.9 % | +2.3 % | View data | |
27 |
#27
South Korea
|
217 | 2019 | -0.5 % | +0.5 % | View data |